SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Keith Feral who wrote (273)9/19/2007 6:17:55 PM
From: Keith FeralRead Replies (1) of 418
 
Good CC from the ThinkEquity Biotech conference. Early 4th quarter for phase 2 b data, expanded phase 3 into Europe, complete enrollment for vinorelbine this quarter, looking for partner for chitosen gel to compete with Zicam, launch 505b2 trial for docetaxel in 4Q, get other drugs ready for 505b2 trials, prepare thiovir for clinical trials in 2Q 2008. Lot's of news coming up.

7 trading days til we get to the beginning of the 4th quarter!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext